
Enhanced pain relief – long term benefit in OA patients.¹⋅
Clinically tested – validated in multiple peer-reviewed studies ²⋅
Scientifically validated – outcome consistency backed by data ³⋅
Reduced inflammation swelling– improves patient satisfaction⁴⋅


Platelet concentration
The speed at which you can upload and download files to and from the cloud.
~7-8x
~2.5-4x
~1.5-2x
WBC Reduction
The largest file size you can upload in a single action.
>90%
~40–50%
~60–70%
Platelet Recovery
The total amount of cloud storage space allocated for your files.
>90%
~60-70%
~20-25%
Output Volume
The speed at which you can upload and download files to and from the cloud.
4–10 ml LP-PRP
2-5ml
1–3 mL
Blood Volume
The largest file size you can upload in a single action.
25-50ml
10-30ml
10ml
RBC locking
Manage access with a specified number of user accounts per plan.
Present
Varies
Absent
Closed system
Manage access with a specified number of user accounts per plan.
Yes
Partially closed
Partially closed
References
1. Smith et al. 2016 leukocyte-poor PRP knee OA randomized trial LP-PRP showed significant improvement in pain and function over time in knee OA patients. Riboh et al. 2016 leukocyte-poor vs leukocyte-rich PRP meta-analysis LP-PRP demonstrated superior clinical outcomes compared to LR-PRP in intra-articular use.
2. Filardo et al. 2012 PRP knee OA clinical trial leukocyte-poor subgroup Cole et al. 2017 PRP vs HA knee OA randomized trial
3. Riboh et al. 2016 PRP formulation meta-analysis leukocyte effect Highlights consistency and better safety profile with LP-PRP. Di Martino et al. 2019 PRP variability and outcomes review Supports reproducibility when PRP composition is controlled (like LP-PRP).
4. Sundman et al. 2011 leukocyte-rich vs poor PRP inflammatory response study Leukocyte-rich PRP increases pro-inflammatory cytokines; LP-PRP shows a more favorable inflammatory profile. Riboh et al. 2016 leukocyte-poor PRP reduced adverse reactions LP-PRP associated with lower post-injection inflammation and better tolerance.
























